Key Takeaways
- J-1 visa holders who own medical device companies, health technology businesses, or medical equipment distribution companies qualify for up to $5M in revenue-based funding — no green card required.
- Medical device businesses with recurring B2B hospital and clinic sales generate strong monthly deposit patterns that Bankable's underwriting recognizes as premium qualification evidence.
- SBIR and SBA lending programs require citizenship — Bankable provides J-1 medical technology founders the institutional revenue-based alternative.
- Funding can be deployed for clinical trial support, FDA 510(k) submission costs, sales force hiring, distributor partnership development, and inventory for product launches.
- Bankable's 48-hour decision cycle enables medical device companies to fund manufacturing runs, regulatory submissions, and sales expansion without bank delays.
Medical device companies represent one of the most intellectually intensive business categories in the US economy. J-1 researchers, physicians, and biomedical engineers have founded hundreds of medical device companies that address real clinical needs with engineered solutions. These companies — from Class I device distributors to Class II cleared device manufacturers — generate real B2B revenue from hospital systems, physician practices, and medical distributors.
The capital challenge for J-1 medical device founders is multi-layered: FDA clearance processes are expensive, clinical evidence generation requires investment ahead of revenue, and sales cycle length in the medical device market means revenue often lags investment by 12-24 months. When these companies do generate revenue, they often face citizenship-based exclusions from SBIR, SBA, and traditional bank lending. Bankable evaluates your medical device business on its actual monthly revenue deposits and delivers a decision in 48 hours.
Revenue-Generating Medical Device Companies That Qualify
Bankable funds medical device companies that are generating documented revenue — not pre-revenue startups seeking seed capital. If your company has received FDA clearance or 510(k) exemption, has active distributor relationships or direct sales, and deposits $15,000 or more monthly in your business bank account, you are a strong candidate for Bankable revenue-based funding. Medical equipment distributors, contract manufacturers, and device service companies also qualify on the same revenue-first basis.
Qualifying Requirements for J-1 Medical Device Companies
Submit your SSN, your company's EIN, and 3 months of business bank statements. Medical device companies should use their primary operating account, not accounts holding regulatory or R&D reserve funds.
| Requirement | Bankable Standard |
|---|---|
| SSN | Required — J-1 holders qualify |
| EIN | Required — registered medical device entity |
| Monthly Revenue | $15,000+ in B2B device sales deposits |
| FDA Registration | Required for device sales — not pledged as collateral |
| Time in Business | 3+ months with documented device revenue |
| Green Card | Not required |
| Patents or IP | Not required as collateral |
How Medical Device Companies Use Bankable Capital
Medical device capital needs span regulatory compliance, manufacturing, sales, and distribution. Bankable funding is unrestricted and can be deployed across all of these growth priorities.
- Manufacturing production runs: Fund inventory production runs to meet distributor purchase orders and hospital system procurement agreements.
- Regulatory submission: Cover FDA 510(k) submission fees, clinical study costs, and quality system documentation required for clearance or expanded indications.
- Sales force hiring: Fund medical device sales representative salaries, commissions, and territory development during the ramp-up to revenue productivity.
- Distributor partnerships: Finance the stocking requirements, marketing support, and product training that distributors require to carry your device.
- Clinical evidence generation: Fund clinical evaluations, case study development, and KOL engagement programs that support market adoption.
- Working capital bridge: Cover manufacturing and overhead costs while waiting for hospital net-60 to net-90 payment cycles.
Check your Bankability Score today to see what your business qualifies for, or review how SBA 7(a) loans compare to Bankable's revenue-based funding.
Frequently Asked Questions
Yes. J-1 visa holders can own US medical device companies. FDA registration and 510(k) clearance are based on the company's compliance profile, not the owner's immigration status.
No. Bankable qualifies medical device businesses on monthly revenue, SSN, and EIN. No green card required.
Bankable funds companies generating documented revenue. For Class I exempt devices, FDA clearance is not required. For Class II devices, 510(k) clearance is needed to sell — which means revenue-generating companies typically have it.
No. Bankable requires documented monthly revenue. Pre-revenue companies should pursue SBIR grants, angel investment, or venture capital until they establish commercial revenue.
Bankable requires $15,000+ in average monthly deposits from device sales, service contracts, or distribution fees.
Yes. Medical equipment distributors with documented B2B sales revenue qualify for Bankable funding.
Decisions are issued within 48 hours. Funds arrive 3–5 business days after approval.
Yes. Quality management system implementation and certification costs are a legitimate use of Bankable working capital.
Yes. US-based device companies with export revenue deposited to US accounts qualify. International revenue counts.
Yes. Bankable's revenue-based funding is compatible with SBIR grants. The two funding sources serve different needs and can coexist.